SCHEMBL17742506

CC1C(O)[C@H](O[C@@H]2OC(CO[C@H]3OC(CO)[C@@H](O)C(O)[C@H]3O[C@@H]3O[C@@H](CO)[C@@H](O[C@@H]4OC(CO[C@]5(C(=O)O)C[C@@H](O)[C@@H](N)C([C@H](O)[C@H](O)CO)O5)[C@H](O)C(O)[C@@H]4O)C(O)C3C)[C@@H](O)C(O[C@H]3O[C@H](CO)[C@@H](O)C(O)C3O[C@@H]3OC(CO)[C@@H](O[C@@H]4OC(CO[C@]5(C(=O)O)C[C@@H](O)[C@@H](N)C([C@H](O)[C@H](O)CO)O5)[C@H](O)C(O)[C@@H]4O)C(O)[C@@H]3C)[C@H]2O)C(CO)O[C@H]1O[C@@H]1C(CO)O[C@@H](C)C(C)C1O

nearest known ligand 0.50

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	SIGLEC7	Q9Y286	6/20	0.50

▸	MAG	P20916	6/20	0.47

▸	SELL	P14151	1/20	0.43

▸	SELP	P16109	1/20	0.43

▸	CD209	Q9NNX6	2/20	0.41

▸	SELE	P16581	2/20	0.40

▸	ENGASE	Q8NFI3	1/20	0.38

▸	CD22	P20273	1/20	0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL17546163	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL18934134	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL15849863	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL16190363	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL18333557	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL16312464	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL16190374	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL18934158	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL17546157	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209
SCHEMBL16348265	1.00	SIGLEC7 (0.50)	SIGLEC7MAGSELLSELPCD209

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20160129150-A1	SUGAR CHAIN-POLYPEPTIDE COMPLEX	GLYTECH, INC. (JP)	2016-05-12	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20160129150-A1	SUGAR CHAIN-POLYPEPTIDE COMPLEX	IAPP, ENPEP, QPCTL	SIGLEC7 34/4885MAG 2349/4885SELL 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.